Leading telehealth platform provider Zoom plans to use Suki’s artificial intelligence (AI) engine, Suki Platform, to provide AI-generated clinical notes to healthcare institutions.
On Tuesday, Zoom said it is partnering with Suki, a technology company that provides AI voice solutions for healthcare, to offer doctors on its platform an AI scribe capable of taking notes during patient consultations.
Also Read: Healthtech startup Suki raises $70 mn to accelerate product development
Zoom intends to utilize Suki’s AI engine for generating clinical notes and integrating AI features into its solution, aiming to enhance user experience and ultimately improve patient care.
“With over almost 140,000 healthcare institutions globally using the Zoom platform, we feel a great responsibility to leverage the power of AI to drive employee productivity and enhance patient experiences,” said Smita Hashim, chief product officer at Zoom.
“Working together with Suki to provide critical AI-generated clinical note functionality to Zoom Workplace for Clinicians will reduce documentation overhead for clinicians, allowing them to focus on patients,” she added.
Suki Platform enables large and small companies alike to build cutting-edge AI experiences with minimal development effort.
Studies have shown that AI-based clinical notes can reduce physician note-taking by up to 70 per cent, allowing for more time with patients (Mayo Clinic).
“AI is changing the way we interact with the world. Everything from how we communicate to how we use technology to how care is delivered will evolve. Video will be a critical interface in the AI-driven world,” said Punit Soni, Suki founder and CEO.
“We are thrilled to work with Zoom to develop new interaction models and AI that will advance our mission of making healthcare technology invisible and assistive so clinicians can focus on what’s most important: their patients,” he added.
Also Read: Google AI model to help Indian medtech firms prevent unnecessary vision loss
Earlier this month, Suki raised $70 million in a new funding round led by Hedosophia, with a substantial additional investment from Venrock.
The round also saw participation from existing investors, including March Capital, Flare Capital, Breyer Capital, and inHealth Ventures.